Elephantiasis News and Research

RSS
Elephantiasis is a disease that is characterized by the thickening of the skin and underlying tissues, especially in the legs, male genitals.
People with lymphatic filariasis more likely to acquire HIV infection, study shows

People with lymphatic filariasis more likely to acquire HIV infection, study shows

People with filariasis show two to three-fold increased risk for HIV

People with filariasis show two to three-fold increased risk for HIV

PATH and SD/Alere announce commercial availability of two diagnostic tools for NTDs

PATH and SD/Alere announce commercial availability of two diagnostic tools for NTDs

Researchers receive Bill & Melinda Gates Foundation grant to eliminate neglected tropical diseases

Researchers receive Bill & Melinda Gates Foundation grant to eliminate neglected tropical diseases

Smartphone checks blood for parasitic disease

Smartphone checks blood for parasitic disease

Purdue researchers identify new class of chemical insecticides to control mosquitoes

Purdue researchers identify new class of chemical insecticides to control mosquitoes

DNDi awarded USAID grant to develop new treatments for river blindness, elephantiasis

DNDi awarded USAID grant to develop new treatments for river blindness, elephantiasis

Gates Foundation provides $2 million grant to help fight major parasitic diseases

Gates Foundation provides $2 million grant to help fight major parasitic diseases

Celgene Global Health, DNDi expand partnership to identify new drug candidates for NTDs

Celgene Global Health, DNDi expand partnership to identify new drug candidates for NTDs

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

Researchers developing new medication to tackle river blindness and elephantiasis

Researchers developing new medication to tackle river blindness and elephantiasis

GHIT Fund announces grants to speed up innovative drug development for neglected diseases

GHIT Fund announces grants to speed up innovative drug development for neglected diseases

LSTM and University of Liverpool receive GHIT Fund to target lymphatic filariasis and onchocerciasis

LSTM and University of Liverpool receive GHIT Fund to target lymphatic filariasis and onchocerciasis

New tools for neglected diseases: an interview with Dr. BT Slingsby, CEO, GHIT Fund

New tools for neglected diseases: an interview with Dr. BT Slingsby, CEO, GHIT Fund

Eisai supplies diethylcarbamazine citrate 100 mg tablets to WHO

Eisai supplies diethylcarbamazine citrate 100 mg tablets to WHO

LSTM professor awarded The Manson Medal for outstanding contribution in field of tropical medicine

LSTM professor awarded The Manson Medal for outstanding contribution in field of tropical medicine

Low-cost intervention reduces transmission of lymphatic filariasis to undetectable levels

Low-cost intervention reduces transmission of lymphatic filariasis to undetectable levels

DFID awards 5-year grant to DNDi to advance research and development for neglected diseases

DFID awards 5-year grant to DNDi to advance research and development for neglected diseases

Human filariasis research: an interview with Professor Mark Taylor, Liverpool School of Tropical Medicine

Human filariasis research: an interview with Professor Mark Taylor, Liverpool School of Tropical Medicine

Liverpool School of Tropical Medicine receives US$ 10 million to continue research against human filariasis

Liverpool School of Tropical Medicine receives US$ 10 million to continue research against human filariasis